RNS Number : 7031U
GlaxoSmithKline PLC
16 May 2008
GlaxoSmithKline plc (the 'Company') announces that in accordance with the authority
granted by shareholders at the Company's Annual
General Meeting on 23 May 2007 it purchased 2,200,000 of its Ordinary shares of 25 pence each
('shares') on 16 May 2008 at a price of
1,135.1 pence per share.
The shares will be cancelled.
Following the cancellation of these shares, the Company holds 484,194,158 of its shares in
Treasury, representing 9.03% of the total
voting rights in the Company.
The Company has 5,359,727,796 shares in issue (excluding Treasury shares). This number
represents the total voting rights in the Company
and may be used by shareholders as the denominator for the calculations by which they can
determine if they are required to notify their
interest in, or a change to their interest in the Company under the Financial Services
Authority's Disclosure and Transparency Rules.
This announcement does not constitute, or form part of, an offer or any solicitation of an
offer to purchase or subscribe for securities
in any jurisdiction and is in conformity with the Financial Services Authority's Disclosure
and Transparency Rules.
This information is provided by RNS
The company news service from the London Stock Exchange
END
POSILFEEESIRLIT
|